Article
UPDATED: Researchers shutter 2 Covid-19 studies as monitors flag Eli Lilly antibodies as a flop for
Rating:
0.0
Views:
155
Likes:
1
Library:
1
Two weeks after the safety data monitoring group advised researchers to hit the hold button on a clinical trial of Eli Lilly's antibody bamlanivimab (LYCoV55) for patients hospitalized with Covid-19, the trial overseers are back with fresh directions to shutter the study after losing faith that the drug could help
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value